Regis Reveals New Potent Compound Capabilities at InformEx 2015

February 3, 2015
Pharmaceutical Technology Editors

Regis Technologies announced it will unveil its new potent compound capabilities at InformEx 2015, Feb. 3-5.

 

Regis Technologies, a contract manufacturing organization (CMO), announced that Wayne Nowicki, director of business development for the company, unveiled the details of its Potent Compound Suite (PCS) at a press conference held on Feb. 3, 2015. An expansion to the company’s Morton Grove, Illinois facility will give the PCS the ability to provide for small molecule cGMP manufacturing of potent compounds up to about one kilogram per batch.

According to a press release, the project was designed and constructed based on existing potent-compound handling requirements. The facility needed to be specially equipped with isolators, laminar flow hoods, and local exhaust ventilation to minimize containment risks. After a facility redesign, including relocation of chemical storage and office construction of new offices, Regis worked with Flow Sciences, a design and manufacture containment solution for research and development laboratories, to manufacture the containment isolator.

According to Flow Sciences, its containment solutions protect operators from exposure to hazardous particulates and vapors while performing operations.

Sources:
PR WebRegisInformExFlow Sciences

Related Content:

PharmTech News | Supplier News